Codexis Inc (CDXS) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.36 (+3.03%), Market cap $0.23B, 52-week low–high $0.98 ~ $3.33.
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Financial statements, price targets, institutional (13F) holdings and related news for Codexis Inc are updated in real time on BlackAll Trade.
Codexis Inc trades at $1.36 (+3.03%). Real-time quotes and charts are available on BlackAll Trade.
Codexis Inc has a market cap of about $0.23B.
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in